Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 7751-7800 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT05409664
Moving Forward Together 4
NAActive, not recruiting
68 participants
Started: Nov 10, 2022 · Completed: Jan 31, 2026
2 conditions4 sponsors1 location
NCT05745090
N-terminal Pro-B-type Natriuretic Peptide (NT-proBNP) in Type 2 Diabetes Mellitus
N/AActive, not recruiting
1,200 participants
Started: Nov 10, 2022 · Completed: Apr 30, 2029
3 conditions2 sponsors1 location
NCT05578703
ABLATE WEIGHT (Ablation Plus ESG for Weight Loss)
NAActive, not recruiting
10 participants
Started: Nov 9, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05593029
A Trial of the Safety and Efficacy of SEP-363856 in the Treatment of Adults With Major Depressive Disorder
PHASE2Active, not recruiting
900 participants
Started: Nov 9, 2022 · Completed: Nov 14, 2025
1 condition1 sponsor76 locations
NCT05358639
Combination of Olaparib and Navitoclax in Women with HGSC and TNBC
PHASE1Active, not recruiting
36 participants
Started: Nov 9, 2022 · Completed: Apr 28, 2025
3 conditions4 sponsors3 locations
NCT05648786
Socializing a Science-Based Digital Therapeutic for Substance Use Disorders
NAActive, not recruiting
189 participants
Started: Nov 9, 2022 · Completed: Dec 31, 2024
2 conditions2 sponsors1 location
NCT05595486
Baby2Home (B2H) Mobile Health Application
NAActive, not recruiting
642 participants
Started: Nov 9, 2022 · Completed: Sep 30, 2025
5 conditions3 sponsors2 locations
NCT05499390
AK112 in Advanced Non-Small Cell Lung Cancer
PHASE3Active, not recruiting
398 participants
Started: Nov 9, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05455931
Real World Observational Study of Poteligeo in Adult Patients With MF and SS (PROSPER)
N/AActive, not recruiting
73 participants
Started: Nov 9, 2022 · Completed: Aug 7, 2025
1 condition1 sponsor19 locations
NCT04454476
Reversal of Preneoplastic Metaplasia in the Stomach With MEK Inhibitor
PHASE1Active, not recruiting
15 participants
Started: Nov 9, 2022 · Completed: Dec 31, 2025
4 conditions1 sponsor3 locations
NCT05174221
A Study of Mezagitamab in Adults With Primary Immunoglobulin A Nephropathy Receiving Stable Background Therapy
PHASE1Active, not recruiting
16 participants
Started: Nov 9, 2022 · Completed: Mar 23, 2026
2 conditions1 sponsor26 locations
NCT05744830
The Effect of a Removable Complete Denture Over One Implant in the Lower Jaw on Hearing Ability
NAActive, not recruiting
30 participants
Started: Nov 8, 2022 · Completed: Sep 26, 2025
1 condition2 sponsors1 location
NCT07213141
Incidence of Graves' Disease After COVID-19 Vaccination
N/AActive, not recruiting
161 participants
Started: Nov 8, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor3 locations
NCT04881630
Mobile Contingency Management for Smoking Cessation
NAActive, not recruiting
532 participants
Started: Nov 8, 2022 · Completed: Sep 30, 2025
1 condition5 sponsors1 location
NCT05486104
Phase II Study of Hemay005 in Patients With Active Ulcerative Colitis
PHASE2Active, not recruiting
92 participants
Started: Nov 8, 2022 · Completed: Dec 30, 2025
1 condition1 sponsor18 locations
NCT05509413
DEFLAGYN® Vaginal Gel and Spontaneous Remission and Regression of Unclear Cervical Smears and HPV High-risk Infections
NAActive, not recruiting
168 participants
Started: Nov 8, 2022 · Completed: Jul 31, 2025
2 conditions1 sponsor1 location
NCT05608746
Prehabilitation in Prostate Cancer Patients, TelePrehabTrial
NAActive, not recruiting
40 participants
Started: Nov 8, 2022 · Completed: Jun 30, 2025
1 condition2 sponsors1 location
NCT05444257
A Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy
PHASE3Active, not recruiting
822 participants
Started: Nov 8, 2022 · Completed: Oct 30, 2026
1 condition1 sponsor195 locations
NCT05563844
Study of Purinostat Mesylate for Injection in the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL)
PHASE2Active, not recruiting
74 participants
Started: Nov 8, 2022 · Completed: Dec 1, 2026
1 condition1 sponsor2 locations
NCT05698017
Study to Evaluate Investigational Allogeneic Cell Therapy Product hOMSC300 for Treatment of Early to Moderate Stage Multiple System Atrophy (MSA)
PHASE1Active, not recruiting
10 participants
Started: Nov 7, 2022 · Completed: Feb 19, 2026
2 conditions1 sponsor1 location
NCT06808113
Circulating and Molecular Markers Involved in the Processes of Cachexia, Anorexia and Sarcopenia in Patients With NSCLC
N/AActive, not recruiting
40 participants
Started: Nov 7, 2022 · Completed: Aug 31, 2027
1 condition1 sponsor1 location
NCT05211869
T1DTechCHW: Enhancing the Community Health Worker Model to Promote Diabetes Technology Use in Young Adults From Underrepresented Minority Groups
NAActive, not recruiting
119 participants
Started: Nov 7, 2022 · Completed: Dec 31, 2025
4 conditions3 sponsors1 location
NCT05549323
A Study to Learn About the Safety, Effects and Pharmacokinetics of Study Medication (PF-07054894) for the Treatment of Ulcerative Colitis
PHASE1Active, not recruiting
40 participants
Started: Nov 7, 2022 · Completed: Jan 14, 2026
1 condition1 sponsor17 locations
NCT05498155
Study of Neoadjuvant Olaparib Monotherapy and Olaparib and Durvalumab Combination in HER2 Negative BRCAm Breast Cancer
PHASE2Active, not recruiting
50 participants
Started: Nov 7, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor37 locations
NCT05648396
Japan FFRangio Clinical Outcomes Study
N/AActive, not recruiting
2,500 participants
Started: Nov 7, 2022 · Completed: Dec 31, 2027
1 condition7 sponsors1 location
NCT05615038
A Comparison of Contact Aspiration Versus Stent Retriever for Acute Basilar Artery Occlusion
NAActive, not recruiting
338 participants
Started: Nov 7, 2022 · Completed: Jun 30, 2025
2 conditions1 sponsor6 locations
NCT05575492
A Study of mRNA-1647 Cytomegalovirus Vaccine in Healthy Participants 9 to 15 Years of Age and Participants 16 to 25 Years of Age
PHASE1/PHASE2Active, not recruiting
873 participants
Started: Nov 7, 2022 · Completed: Jan 15, 2027
1 condition1 sponsor60 locations
NCT05652283
Pamiparib Combined With Surufatinib for the Neoadjuvant Treatment of Unresectable Ovarian Cancer
PHASE2Active, not recruiting
37 participants
Started: Nov 6, 2022 · Completed: May 1, 2026
1 condition1 sponsor1 location
NCT05569525
Type I Diabetes and Non-surgical Periodontal Treatment
NAActive, not recruiting
100 participants
Started: Nov 6, 2022 · Completed: Dec 10, 2025
6 conditions1 sponsor1 location
NCT05522361
Risdiplam in Patients With Spinal Muscular Atrophy Previously Treated With Nusinersen
PHASE4Active, not recruiting
10 participants
Started: Nov 6, 2022 · Completed: Jun 15, 2026
1 condition2 sponsors1 location
NCT05575128
Behavioral Activation and Medication Optimization In Older Adults Undergoing Cardiac Procedures
NAActive, not recruiting
102 participants
Started: Nov 5, 2022 · Completed: Mar 31, 2025
4 conditions2 sponsors1 location
NCT05373537
Treatment to Improve Sleep in Caregivers With Insomnia and a Child With Autism
NAActive, not recruiting
80 participants
Started: Nov 5, 2022 · Completed: Dec 15, 2025
3 conditions2 sponsors2 locations
NCT06600594
The Effect of Dance Training on Psychomotor, Biomechanical and Biochemical Parameters in Adults
NAActive, not recruiting
81 participants
Started: Nov 5, 2022 · Completed: Sep 30, 2025
4 conditions1 sponsor1 location
NCT05759520
Phase III Clinical Trial of 13-valent Pneumococcal Conjugate Vaccine (Multivalent Conjugate) in Infants
PHASE3Active, not recruiting
1,800 participants
Started: Nov 4, 2022 · Completed: Jun 30, 2025
1 condition1 sponsor5 locations
NCT05597267
The MIRIA Acne Scar Study
NAActive, not recruiting
75 participants
Started: Nov 4, 2022 · Completed: Feb 28, 2025
1 condition1 sponsor3 locations
NCT05473299
Xeltis Hemodialysis Access Graft: aXess Pivotal Study
NAActive, not recruiting
120 participants
Started: Nov 4, 2022 · Completed: Dec 31, 2029
1 condition1 sponsor22 locations
NCT05364424
A Study Evaluating the Efficacy, Safety, and Pharmacokinetics of Glofitamab in Combination With Rituximab Plus Ifosfamide, Carboplatin Etoposide Phosphate in Participants With Relapsed/Refractory Transplant or CAR-T Therapy Eligible Diffuse B-Cell Lymphoma
PHASE1Active, not recruiting
43 participants
Started: Nov 4, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor9 locations
NCT05614102
A First-in-human Study to Learn How Safe the Study Drug BAY2965501 is, Find the Best Dose (Single Drug & Combination), How it Affects the Body, What Maximum Amount Can be Given, How it Moves Into, Through and Out of the Body, How it Acts on Different Tumors in Participants With Advanced Solid Tumors
PHASE1Active, not recruiting
284 participants
Started: Nov 4, 2022 · Completed: Sep 9, 2027
1 condition1 sponsor21 locations
NCT06054269
Clinical Trial to Evaluate the Immunogenicity of an Adjuvanted Influenza Vaccine Among HCP
PHASE3Active, not recruiting
192 participants
Started: Nov 4, 2022 · Completed: Mar 31, 2026
1 condition5 sponsors2 locations
NCT05170425
LAMBDA 002 (Lung Registry) Study
N/AActive, not recruiting
154 participants
Started: Nov 4, 2022 · Completed: May 31, 2027
1 condition1 sponsor11 locations
NCT05283148
Sickle Cell Disease (SCD) Bone Pain Study
NAActive, not recruiting
53 participants
Started: Nov 3, 2022 · Completed: Jul 31, 2026
10 conditions3 sponsors1 location
NCT05571462
Mobility and Activity Patterns in Hospitalised Severe Brain Injury
N/AActive, not recruiting
100 participants
Started: Nov 3, 2022 · Completed: Apr 30, 2024
1 condition2 sponsors1 location
NCT05553925
Partnerships for Reducing Overweight and Obesity with Patient-Centered Strategies 2.0
NAActive, not recruiting
5,000 participants
Started: Nov 3, 2022 · Completed: Aug 28, 2025
2 conditions2 sponsors1 location
NCT05498090
Interrogating Fatty Acid Metabolism Impairment and Clinical Correlates in Males with Klinefelter Syndrome
PHASE4Active, not recruiting
44 participants
Started: Nov 3, 2022 · Completed: Aug 30, 2025
1 condition2 sponsors1 location
NCT05468424
Effect of Tablet-Based Games on Executive Functions in Older Adults With Mild Cognitive Impairment
NAActive, not recruiting
42 participants
Started: Nov 3, 2022 · Completed: Jun 24, 2024
1 condition1 sponsor2 locations
NCT05441514
Enasidenib in Combination With Cobimetinib for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
PHASE1Active, not recruiting
3 participants
Started: Nov 3, 2022 · Completed: May 3, 2027
2 conditions2 sponsors1 location
NCT05331625
Understanding Quality of Life Among Patients with Cancer Receiving Palliative Care
NAActive, not recruiting
208 participants
Started: Nov 3, 2022 · Completed: Aug 31, 2025
1 condition1 sponsor1 location
NCT05608876
A Clinical Study to Investigate the Efficacy of Tigilanol Tiglate Directly in Head and Neck Cancer
PHASE2Active, not recruiting
15 participants
Started: Nov 3, 2022 · Completed: Aug 31, 2026
1 condition1 sponsor7 locations
NCT05807529
A Study to Evaluate the Safety and Efficacy of 2ccPA in Patients With Symptomatic Knee Osteoarthritis
PHASE1/PHASE2Active, not recruiting
136 participants
Started: Nov 3, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT06445985
Hydrotherapy in Duchenne Muscular Dystrophy (DMD)
NAActive, not recruiting
31 participants
Started: Nov 2, 2022 · Completed: Dec 12, 2025
1 condition2 sponsors1 location